ARS Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov '25 Nov 19, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	715	1,025	526	800	-	-
Market Cap Growth	-49.92%	94.90%	-34.23%	-	-	-
Enterprise Value	584	821	284	839	-	-
Last Close Price	7.08	10.55	5.48	8.53	-	-
PE Ratio	-	128.20	-	-	-	-
PS Ratio	4.87	11.50	17535.50	607.80	-	-
PB Ratio	4.74	3.99	2.28	2.93	-	-
P/TBV Ratio	5.29	4.12	2.29	2.93	-	-
P/FCF Ratio	-	78.96	-	-	-	-
P/OCF Ratio	-	75.68	-	-	-	-
EV/Sales Ratio	4.09	9.21	9483.00	637.20	-	-
EV/FCF Ratio	-	63.20	-	-	-	-
Debt / Equity Ratio	1.15	0.27	0.00	0.00	0.20	1.40
Debt / FCF Ratio	-	5.35	-	-	-	1.10
Asset Turnover	0.48	0.31	0	0.01	0.13	-
Quick Ratio	6.41	13.79	95.80	50.59	7.34	3.03
Current Ratio	6.66	14.26	96.92	51.01	7.42	3.21
Return on Equity (ROE)	-45.92%	3.28%	-21.59%	-21.84%	-77.93%	-
Return on Assets (ROA)	-19.22%	-0.66%	-16.40%	-12.56%	-27.68%	-
Return on Capital (ROIC)	-21.88%	-0.69%	-16.73%	-13.17%	-34.25%	-
Return on Capital Employed (ROCE)	-28.20%	-0.90%	-29.30%	-12.50%	-36.50%	-2.60%
Earnings Yield	-11.39%	0.78%	-10.33%	-4.34%	-	-
FCF Yield	-12.24%	1.27%	-11.30%	-5.04%	-	-
Buyback Yield / Dilution	-1.59%	-7.54%	-138.30%	-38.39%	-42.81%	-

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q